Edward J. Dulac III - EVP, Chief Financial Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

Edward J. Dulac III - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Edward J. Dulac III for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 106,062 $1,486,989 $14.02 23 Jul 2025 Direct
Stock Option (right to buy) 67,429 01 Mar 2025 Direct Common Stock

Transactions reported by Edward J. Dulac III for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.